Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 23, Issue -, Pages S140-S145Publisher
WILEY-BLACKWELL PUBLISHING, INC
DOI: 10.1111/j.1440-1746.2008.05552.x
Keywords
advanced glycation end-product; ELISA; inflammatory bowel disease; pentosidine; ulcerative colitis; urine
Categories
Funding
- Saitama Medical University
Ask authors/readers for more resources
Under inflammatory conditions with strong oxidative stresses, advanced glycation end-products (AGE), carbonyl compounds, are produced. The concentration of pentosidine, an AGE, reportedly correlates with complications of diabetes mellitus and worsening of rheumatoid arthritis, but its role in the pathogenesis of inflammatory bowel diseases (IBD) is unclear. Immunohistochemistry was performed with antibodies against pentosidine, and 8-OH-2-deoxyguanosine. The urinary concentration of pentosidine was also quantified by enzyme-linked immunosorbent assay method. Pentosidine expression was up-regulated in the inflamed tissue of IBD. The expression of both pentosidine and 8-OH-2-deoxyguanosine was similar and increased in the inflamed epithelium and infiltrating cells (neutrophils and lymphocytes). The urinary concentration of pentosidine in active ulcerative colitis was significantly greater than that in inactive ulcerative colitis (0.12 +/- 0.15 vs 0.021 +/- 0.011 mu g/mg of Cr, P < 0.05), and was greater in active Crohn's disease than in inactive Crohn's disease (0.071 +/- 0.086 vs 0.039 +/- 0.023 mu g/mg of Cr). The urinary pentosidine level correlated with the activity of ulcerative colitis and may be a marker for disease activity in ulcerative colitis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available